ALS-specific peptide composition
The invention relates to an epitope protection assay for use in diagnosis, prognosis and therapeutic intervention in diseases, for example, involving polypeptide aggregation, such as prion infections. The methods of the invention first block accessible polypeptide target epitope with a blocking agent. After denaturation of the polypeptide, a detecting agent is used to detect protein with target epitope that was inaccessible during contact with the blocking agent. The invention also relates to novel amyotrophic lateral sclerosis-specific epitopes and their uses to make antibodies, and to the novel antibodies and uses thereof.
1. A composition for eliciting an immune response in an animal to produce an antibody that binds selectively to an amyotrophic lateral sclerosis (ALS)-specific epitope, the composition comprising an effective amount of the isolated ALS-specific epitope in admixture with a suitable diluent or carrier, wherein the ALS-specific epitope is an isolated peptide consisting of the amino acid sequence DLGKGGNEESTKTGNAGS (SEQ ID NO:1).
2. The composition of claim 1 , further comprising an adjuvant.
3. The composition of claim 2 , wherein the epitope is conjugated to a molecule that enhances immunogenicity of the epitope.
4. The composition of claim 3 , wherein the molecule comprises keyhole limpet hemocyanin.